STOCK TITAN

NeuroOne Medical Technologies Corporation - NMTC STOCK NEWS

Welcome to our dedicated page for NeuroOne Medical Technologies Corporation news (Ticker: NMTC), a resource for investors and traders seeking the latest updates and insights on NeuroOne Medical Technologies Corporation stock.

NeuroOne Medical Technologies Corporation (symbol: NMTC) is a cutting-edge medical technology company based in Eden Prairie, Minnesota. The company specializes in the development and commercialization of innovative thin-film electrode technology designed for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, brain stimulation, and ablation solutions. These technologies are particularly beneficial for patients suffering from a variety of brain-related disorders, including epilepsy, Parkinson's disease, dystonia, and essential tremors.

NeuroOne's core business revolves around creating comprehensive neuromodulation solutions that integrate cEEG and sEEG recording, monitoring, brain stimulation, and ablation. This focus has led to notable advancements such as the Evo® sEEG system, which is the first FDA-cleared thin-film sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue, with the added benefit of temperature control.

The company is actively involved in various exciting projects and partnerships. One of their key initiatives is the Drug Delivery Program, which is expected to achieve several important milestones in the near future. Additionally, NeuroOne is continuously enhancing its product portfolio to better serve its target patient population.

Financially, NeuroOne has provided promising updates for the second quarter of the fiscal year 2024. The company’s recent business highlights include significant progress in their OneRF™ Ablation System and Spinal Cord Stimulation Program. Investors and interested parties can access more detailed financial results and updates through their quarterly conference calls and webcasts.

For more information or to get in touch with NeuroOne, please contact them at 800-631-4030 or email ir@nmtc1.com.

Rhea-AI Summary
NeuroOne to present at H.C. Wainwright Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.01%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.76%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.9%
Tags
conferences earnings
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.33%
Tags
-
Rhea-AI Summary
NeuroOne Medical Technologies Corporation (NMTC) Announces Commencement of Proposed Public Offering to Support Product Launch and FDA Submission
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-33.33%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.5%
Tags
none
Rhea-AI Summary
NeuroOne Medical Technologies Corporation announced the first clinical case using the Evo sEEG electrode in robotic neurosurgery. The procedure was performed at Cleveland Clinic using Zimmer Biomet's ROSA One Brain. NeuroOne's CEO commented that this milestone confirms the synergistic use of their product with Zimmer Biomet's robotics platform.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.77%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
conferences earnings
Rhea-AI Summary
NeuroOne Medical Technologies announced the successful use of its Evo sEEG electrode in a clinical case at Mayo Clinic. The electrodes were implanted using a non-robotic stereotactic frame system and met the company's performance objectives. The CEO expressed excitement about the initial performance and plans to launch the technology through their distribution partner, Zimmer Biomet. NeuroOne aims to expand market adoption of sEEG technology in the US.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.5%
Tags
none

FAQ

What is the current stock price of NeuroOne Medical Technologies Corporation (NMTC)?

The current stock price of NeuroOne Medical Technologies Corporation (NMTC) is $0.7582 as of December 20, 2024.

What is the market cap of NeuroOne Medical Technologies Corporation (NMTC)?

The market cap of NeuroOne Medical Technologies Corporation (NMTC) is approximately 23.1M.

What does NeuroOne Medical Technologies Corporation focus on?

NeuroOne focuses on developing and commercializing thin-film electrode technology for cEEG and sEEG recording, brain stimulation, and ablation solutions.

Where is NeuroOne Medical Technologies Corporation based?

The company is based in Eden Prairie, Minnesota.

What disorders does NeuroOne's technology address?

Their technology addresses brain-related disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors.

What is the Evo® sEEG system?

The Evo® sEEG system is an FDA-cleared thin-film sEEG-guided RF system that can record electrical activity and ablate nervous tissue with temperature control.

What are some of NeuroOne's current projects?

Current projects include the Drug Delivery Program and the OneRF™ Ablation System, among others.

How can I contact NeuroOne Medical Technologies Corporation?

You can contact them at 800-631-4030 or email ir@nmtc1.com.

What recent financial updates has NeuroOne provided?

In the second quarter of fiscal year 2024, NeuroOne reported progress in the OneRF™ Ablation System and Spinal Cord Stimulation Program.

What type of medical technology does NeuroOne specialize in?

NeuroOne specializes in neuromodulation technology, particularly thin-film electrode technology for cEEG and sEEG recording, brain stimulation, and ablation.

What is the significance of the FDA clearance for NeuroOne's technology?

The FDA clearance for the Evo® sEEG system signifies the approval and safety of the technology for medical use, affirming its efficacy in recording electrical activity and ablating nervous tissue.

Where can I find more detailed financial results and updates about NeuroOne?

Detailed financial results and updates can be accessed through quarterly conference calls and webcasts organized by the company.

NeuroOne Medical Technologies Corporation

Nasdaq:NMTC

NMTC Rankings

NMTC Stock Data

23.13M
25.58M
16.02%
19.43%
0.35%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
EDEN PRAIRIE